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1. Introduction 
We have shown that the pituitary glands of obese 
mice perifused in series with isolated pancreatic islets 
stimulate insulin release. These experiments were 
carried out with genetically obese mice (ob/ob) [l] 
and mice rendered obese with goldthioglucose or by 
dietary manipulation [2]. Experiments with lean mice 
suggested that the secretion of this insulin releasing 
factor is partly controlled by high caloric intake and 
high levels of circulating glucose [2]. It was proposed 
that the corticotropin-like-intermediate lobe-peptide 
‘CLIP’ [3], (identical to the 18-39 moiety of the 
ACTH molecule), or a closely related peptide was the 
insulin releasing peptide secreted by the neurointer- 
mediate lobe (NIL) of the ob/ob mouse [4-71. 
Further evidence for this conclusion was obtained by 
experiments in which the insulin releasing action of a 
pituitary perifusate was inhibited by treatment with a 
-COOH terminal ACTH antiserum [8]. Now we’have 
done similar experiments using the perfused rat pan- 
creas as the test system. 
To establish the nature of the insulin secretagogue, 
peptide fractions have been separated from the neuro- 
intermediate lobe (NIL) of the ob/ob mouse. Two 
closely related peptide fractions have been isolated by 
gel chromatography which cross react with -COOH 
terminal ACTH antiserum and rapidly stimulate 
insulin release in the perfused rat pancreas. One of 
these shows greater specific activity and has been 
called /Icell tropin. 
2. Experimental 
ob/ob Mice, 2-4 months old were from a strain 
ElsevierlNorth-Holland Biomedical Press 
bred in this Department [9]. The Sprague-Dawley 
rats used were also bred in this Department. 
Purified human serum albumin was from Albumin 
Kabi, Kabivitrium Ltd , Uxbridge Road, London W5. 
Dextran T40 was from Pharrnacia (Gt. Britain) Ltd, 
Hounslow. Insulin binding reagent was from the 
Wellcome Labs., Beckenham and lzsI from the Radio- 
chemical Centre, Amersham. 
Insulin was measured by the radioimmunoassay 
technique in [lo]. 
2.1. Perfusion of rat pancreas 
Sprague-Dawley rats (200-300 g) were anaes- 
thetized with 60 mg sodium pentobarbitone/kg 
and the pancreas isolated by ligating and severing all 
relevant blood vessels to surrounding organs and 
severing all connective tissue except that between the 
pancreas and the stomach, proximal duodenum and 
spleen. The pancreas and attached tissue were placed 
in the well of the warming chamber. 
An open ‘once-through’ perfusion system was 
used. Buffers were gassed in their reservoirs with 95% 
02, 5% O2 for -1 h before use and throughout the 
perfusion. The perfusion fluid was drawn by means of 
a multiple channel peristaltic pump through silicone 
tubing to bubble traps. The perfusion fluid then passed 
to a junction point consisting of a series of two-way 
valves, arranged so that rapid switching from buffer in 
one channel to another occurred prior to the pump. 
The fluid was then pumped through several coils of 
silicone tubing in a perspex warming chamber main- 
tained at 38°C by a flow heater. After emerging 
through the top of the chamber the buffer passed 
through a T junction, the side arm of which led to a 
mercury manometer to enable arterial pressure, which 
must be 60-90mgHg, to be monitored. The perfusate 
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then entered the arterial can&a (fashioned from a 
2 1 gauge needle) in the coeliac artery and was collect- 
ed from the venous cannula (made from 2.1 mm o .d. 
nylon) in the portal vein. One minute fractions were 
collected. The flow rate through the pancreas was 
4.5 ml/m& Insulin was determined in the individual 
fractions by radioimmunoassay. Further details of the 
perfusion technique will be given in [ 111. 
2.2. Pertfusion technique 
The perifusion technique was as in [ l] with modifi- 
cations indicated in the figure legends. 
2.3, Fractionation of the ~e~f~~ate 
Fractionation (based on the te~~ique in [ 121) 
was done on a Biogel I’2 column f I .5 X 30 cm) and a 
Biogei P6 column (1.5 X 90 cm) in series at 4°C. The 
columns were first equilibrated with 5% (v/v) acetic 
acid containing 0.02% (w/v) bovine plasma. The flow 
rate was 3 .O ml/h and 30 min fractions were collected. 
Fractions o collected were then assayed for 14C con- 
tent (0.5 ml of each fraction was added to 4.5 ml 
xylene/Triton X-100 scintillation cocktail). Aliquots 
of the fractions were diluied 1: 10 with mercapto- 
ethanol buffer for immunoassay. Radio~munoassay 
was carried out with -COOH terminal ACTH anti- 
serum using a peptide correspond~g to the 17-39 
moiety of ACTH as standard. Fractions for bioassay 
were lyophilized and reconstituted in the required 
medium (see fig.3). 
F&I. Influence of a perifusate of the pituitary neurointer- 
mediate lobe of the ob/ob mouse on insulin release from a 
perfused rat pancreas. The perfusion buffer contained KC1 
(4.4 mM), calcium gluconate (2.1 mM), KH,PO, (1.5 mM), 
NaHCO,(25 mM),NaCl(llS mM),MgSO, ‘7 H,O (1.2 mM), 
purified human serum albumin (1%) and Dextran T40 (3%). 
It was adjusted to pH 7.4 using 0.1 M HCl and filtered. The 
perifusion buffer was as above but contained only 0.2% 
albumin, this was then diluted 1: 10 with buffer to give a final 
albumin concentration of 1%. 
Table 1 
Inhibition of insulin releasing activity of neurointermediate lobe perifusate by 
-COOH terminal ACTH antiserum 
Expt. 
1 
2 
(a) Perifusate treated with (b) Perifusate treated with 
C-terminal antiserum normal rabbit serum 
136 500 
113 583 
Two 1 ml aliquots of perifusate from 8 obfob mouse neurointermediate lobes 
were incubated overnight at 4’C with: (a) 200 ~1 -COOH terminal ACTH anti- 
serum; and (b) 200 ~1 normal rabbit serum. Each sample was then taken up in 
100 ml perfusion buffer. During each experiment normal perfusion buffer was 
perfused for the first 7 min followed by 5 min perfusion with (a), followed by a 
further 5 min with normal perfusion buffer and then 5 min perfusion with (b) 
(maximal-basal) 
Results expressed as % stimulation of insulin secretion: 
(basal) 
x 100 
304 
Volume 117, number 1 FEBS LETTERS August 1980 
3. Results and discussion 
The results given in the figures are based on single 
experiments, but the findings have been confirmed in 
2-4 further experiments in each case. The viability of 
the perfused pancreas was tested in most experiments 
by stimulation with high glucose concentrations and 
this always produced a typical biphasic response [ 131. 
The results in fig.1 show that a perifusate of the 
NIL of the obese mouse rapidly stimulated insulin 
secretion in the perfused rat pancreas, reaching a 
maximum in l-2 mm and returning to basal levels in 
4-5 min. It was found that the perfused rat pancreas 
is a more reliable and sensitive system for measuring 
insulin stimulation by the pituitary peptide than the 
microdissected pancreatic islets used in [ 1,2,4]. 
The results in table 1 show that if the perifusate is 
pretreated with -COOH terminal ACTH antiserum 
the stimulation of insulin release is markedly inhibited 
as compared to the second challenge with a control 
perifusate pretreated with normal rabbit serum. 
(Experiments submitted for publication have shown 
that when the pancreas was challenged twice with 
untreated NIL perifusate the islets were refractory to 
the second challenge.) These experiments confirm the 
original conclusion discussed above that the active 
insulin releasing factor in NIL perifusate from ob/ob 
mice cross reacts with -COOH terminal ACTH anti- 
serum. 
We decided to fractionate the peptides of the NIL 
perifusates following incubation with [‘4C]proline 
(see legend fig.2) and to test those fractions which 
cross-reacted with -COOH terminal ACTH anti- 
serum for insulin releasing activity. The chromatogram 
obtained from the NIL perifusate of an ob/ob mouse 
(fig.2) showed that in addition to the peaks A and B 
(CLIP) observed in [ 121 using rat pars intermedia, 
there were 3 more small molecular weight fractions 
C, D and E which also cross-reacted with the anti- 
serum. The distribution of r4C in these chromatograms 
is at present under investigation with further purified 
peptide samples. The results in fig.3 show that neither 
CLIP (B) nor fraction C stimulated insulin release. 
Fractions D and E both stimulated insulin release, the 
pattern being very similar to that obtained with the 
whole perifusate. 
Recent experiments involving the further purifica- 
tion and elucidation of the structure of these peptides 
have shown that D, although present in approximately 
equal quantities to E as measured by immunoassay, is 
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Fig.2. Fractionation of peptides from a perifusate of neurointermediate lobes of obese mice. Three groups of 5 neurointermediate 
lobes were incubated for 4 h in 200 J of an incubation medium comprising 100 r.11 TrowelI’s medium and 100 ~10.9% (w/y) saline 
containing 25 j&i [ ‘~]proline. The incubation was carried out in plastic disposable 5 ml tubes in a shaking water bath at 37°C. 
The tubes were thoroughly gassed with 95% 0,:5% CO, and securely stoppered. The lobes were then placed into 2 channels of a 
perifusion block, 8 into one channel and 7 into another and perifused with Krebs-Ringer bicarbonate buffer, containing 0.1% 
(&‘) glucose and 0.2% (w/v) plasma albumin, at 0.67 ml. min-’ _ channel-’ until 100 ml perifusate had been collected. This was 
divided into 4 X 25 ml aliquots and each was placed into a silicon&d 230 ml round-bottomed flask and lyophilized. The 
lyophilized solid was then taken up in 5.0 ml 5% (v/v) acetic acid and fractionated on Biogel columns. 
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in fact present in considerably higher concentration 
than E when estimated by ultraviolet absorption. As 
the stimulation of insulin release above basal levels 
was consistently greater with E, it appears possible 
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that the activity of D is due to some contamination 
with the extremely potent insulin secretagogue, pep- 
tide E. The latter has therefore been called P-cell 
tropin. Work is in progress on the further purification 
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Fig.3. Fractions separated from perifusate of neurointermediate lobes of obese mouse tested on the perfused rat pancreas. The 
lyophilized fractions B-E (see fig.2) (corresponding to 25% of the total prepared from 15 neurointermediate lobes from obese mice) 
were dissolved in 100 ml perfusion buffer and tested on the perfused rat pancreas. 
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of E and the elucidation of its chemical composition. 
&Cell tropin could play a role iu the complex con- 
trol of insulin secretion which leads to the hyper- 
insulinaemia associated with obesity and insulin 
resistance [6,14]. 
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